Zevenbergen Capital Investments LLC Exact Sciences Corp Transaction History

Zevenbergen Capital Investments LLC

  • $4.03 Billion
  • Q1 2025

A detailed history of Zevenbergen Capital Investments LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Zevenbergen Capital Investments LLC holds 1,167,964 shares of EXAS stock, worth $62.7 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
1,167,964
Previous 1,376,057 15.12%
Holding current value
$62.7 Million
Previous $77.3 Million 34.61%
% of portfolio
1.26%
Previous 1.61%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$43.04 - $58.51 $8.96 Million - $12.2 Million
-208,093 Reduced 15.12%
1,167,964 $50.6 Million
Q4 2024

Feb 11, 2025
SELL
$49.33 - $71.97 $2.84 Million - $4.14 Million
-57,518 Reduced 4.01%
1,376,057 $77.3 Million
Q3 2024

Nov 12, 2024
SELL
$42.43 - $70.83 $1.24 Million - $2.08 Million
-29,340 Reduced 2.01%
1,433,575 $97.6 Million
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $4.19 Million - $7.54 Million
101,500 Added 7.46%
1,462,915 $61.8 Million
Q1 2024

May 07, 2024
BUY
$56.27 - $73.77 $13 Million - $17.1 Million
231,591 Added 20.5%
1,361,415 $94 Million
Q4 2023

Feb 08, 2024
BUY
$59.06 - $75.72 $850,404 - $1.09 Million
14,399 Added 1.29%
1,129,824 $83.6 Million
Q3 2023

Nov 01, 2023
SELL
$65.94 - $99.04 $1.71 Million - $2.57 Million
-25,995 Reduced 2.28%
1,115,425 $76.1 Million
Q2 2023

Aug 09, 2023
SELL
$62.68 - $95.05 $5.92 Million - $8.98 Million
-94,463 Reduced 7.64%
1,141,420 $107 Million
Q1 2023

May 11, 2023
SELL
$47.19 - $70.77 $7.05 Million - $10.6 Million
-149,445 Reduced 10.79%
1,235,883 $83.8 Million
Q4 2022

Feb 13, 2023
SELL
$30.35 - $53.15 $3.06 Million - $5.36 Million
-100,920 Reduced 6.79%
1,385,328 $68.6 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $236,961 - $365,930
7,412 Added 0.5%
1,486,248 $48.3 Million
Q2 2022

Aug 11, 2022
SELL
$35.61 - $76.23 $1.81 Million - $3.87 Million
-50,796 Reduced 3.32%
1,478,836 $58.3 Million
Q1 2022

May 12, 2022
SELL
$57.56 - $82.54 $5.05 Million - $7.24 Million
-87,766 Reduced 5.43%
1,529,632 $107 Million
Q4 2021

Feb 11, 2022
SELL
$72.5 - $100.68 $8.99 Million - $12.5 Million
-124,015 Reduced 7.12%
1,617,398 $126 Million
Q3 2021

Nov 12, 2021
SELL
$90.24 - $124.05 $5.82 Million - $7.99 Million
-64,449 Reduced 3.57%
1,741,413 $166 Million
Q2 2021

Aug 11, 2021
SELL
$93.66 - $139.27 $4.87 Million - $7.24 Million
-51,999 Reduced 2.8%
1,805,862 $224 Million
Q1 2021

May 12, 2021
BUY
$116.57 - $155.01 $4.59 Million - $6.11 Million
39,395 Added 2.17%
1,857,861 $245 Million
Q4 2020

Feb 10, 2021
SELL
$99.61 - $142.12 $27.1 Million - $38.7 Million
-272,231 Reduced 13.02%
1,818,466 $241 Million
Q3 2020

Nov 12, 2020
BUY
$72.92 - $102.01 $7.68 Million - $10.7 Million
105,268 Added 5.3%
2,090,697 $213 Million
Q2 2020

Aug 12, 2020
BUY
$55.75 - $92.75 $10.8 Million - $17.9 Million
193,200 Added 10.78%
1,985,429 $173 Million
Q1 2020

May 12, 2020
SELL
$37.9 - $104.44 $59 Million - $163 Million
-1,556,899 Closed
0 $0
Q4 2019

Feb 07, 2020
SELL
$77.66 - $99.74 $10.4 Million - $13.4 Million
-134,181 Reduced 7.93%
1,556,899 $144 Million
Q3 2019

Nov 08, 2019
SELL
$90.37 - $122.49 $5.18 Million - $7.03 Million
-57,363 Reduced 3.28%
1,691,080 $153 Million
Q2 2019

Aug 13, 2019
SELL
$89.51 - $118.04 $8.41 Million - $11.1 Million
-94,002 Reduced 5.1%
1,748,443 $206 Million
Q1 2019

May 14, 2019
SELL
$61.98 - $96.5 $19.4 Million - $30.2 Million
-312,912 Reduced 14.52%
1,842,445 $160 Million
Q4 2018

Feb 14, 2019
SELL
$56.04 - $82.66 $5.47 Million - $8.08 Million
-97,690 Reduced 4.34%
2,155,357 $136 Million
Q3 2018

Nov 13, 2018
BUY
$48.29 - $80.6 $8.83 Million - $14.7 Million
182,877 Added 8.83%
2,253,047 $178 Million
Q2 2018

Aug 14, 2018
BUY
$37.84 - $69.96 $1.35 Million - $2.5 Million
35,725 Added 1.76%
2,070,170 $124 Million
Q1 2018

May 15, 2018
BUY
$39.82 - $57.53 $6.09 Million - $8.8 Million
152,900 Added 8.13%
2,034,445 $82 Million
Q4 2017

Feb 14, 2018
SELL
$46.49 - $60.51 $10.9 Million - $14.2 Million
-234,380 Reduced 11.08%
1,881,545 $98.9 Million
Q3 2017

Nov 09, 2017
BUY
$37.05 - $47.12 $78.4 Million - $99.7 Million
2,115,925
2,115,925 $99.7 Million

Others Institutions Holding EXAS

# of Institutions
645
Shares Held
157M
Call Options Held
1.74M
Put Options Held
1.56M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.49B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Zevenbergen Capital Investments LLC Portfolio

Follow Zevenbergen Capital Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zevenbergen Capital Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zevenbergen Capital Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email